The first biological medicine to be approved for use in the European Union for a particular condition is called the biological reference medicine. A biosimilar medicine is a medicine that has a ...
AbbVie looks set to lose several billion dollars in revenue from Humira, as its soon to expire European patent ... million by switching to biosimilars and generic medicines. The NHS also announced ...
Hosted on MSN11mon
European Commission gives nod to Sandoz’s biosimilar to treat autoimmune disordersSandoz, a key player in generic and biosimilar medicines, announced that the European Commission (EC) has granted marketing authorization for Pyzchiva (biosimilar ustekinumab), developed and ...
The inquiry is the latest effort by the European Commission and European countries to scrutinize potential antitrust behavior ...
INCHEON, South Korea--(BUSINESS WIRE)--Celltrion today announced that the European Commission (EC) has granted marketing authorization for three products across two biosimilars: Eydenzelt ® (CT ...
This latest approval comes after the FDA and European Medicines Agency approved Samsung Bioepis’ denosumab biosimilars, Ospomyv and Xbryk, last month and also granted them interchangeability ...
Otulfi ® was approved by the U.S. Food and Drug Administration (FDA) and the European Medicines ... of high-quality biosimilars, follow-on products of biopharmaceutical medicines.
Celltrion today announced that the European Commission (EC) has granted marketing authorization for three products across two biosimilars: Eydenzelt ® (CT-P42, aflibercept), a biosimilar to Eylea ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback